Cargando…
Reduced S100 Protein Expression in Malignant Ossifying Fibromyxoid Tumors: A Case Report
Ossifying fibromyxoid tumor of soft parts (OFMT) is a rare mesenchymal neoplasm of uncertain lineage. OMFT normally has a benign clinical course, and malignant variants are considered unusual. Criteria defining malignancy have not yet been clearly identified and universally accepted, and there is di...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994011/ https://www.ncbi.nlm.nih.gov/pubmed/33786264 http://dx.doi.org/10.1097/GOX.0000000000003482 |
_version_ | 1783669675487395840 |
---|---|
author | Foster-Davies, Harri Jessop, Zita M. Clancy, Rachel M. Vijayasurej, Kerrin Vass, Johanne Bragg, Thomas Brotto, Maurizio |
author_facet | Foster-Davies, Harri Jessop, Zita M. Clancy, Rachel M. Vijayasurej, Kerrin Vass, Johanne Bragg, Thomas Brotto, Maurizio |
author_sort | Foster-Davies, Harri |
collection | PubMed |
description | Ossifying fibromyxoid tumor of soft parts (OFMT) is a rare mesenchymal neoplasm of uncertain lineage. OMFT normally has a benign clinical course, and malignant variants are considered unusual. Criteria defining malignancy have not yet been clearly identified and universally accepted, and there is diagnostic uncertainty between pathologists as to how best to recognize a malignant variant. We present the case of a 68-year-old male patient who, following initial diagnosis of typical OFMT in the left scapular region, presented to the sarcoma service 9 years later with a short history of a solid lesion in the right calf. Biopsy confirmed metastatic OFMT and further imaging identified three other radiologically similar but distant lesions, which were later resected. The histology of the initial biopsy was reviewed, and the original observations were found to be accurate and due to current diagnostic criteria, the specimen was reported as typical. We propose that this case report contributes to a growing body of literature suggesting that negative S100 expression may be a useful feature in identifying and characterizing malignant OFMT. |
format | Online Article Text |
id | pubmed-7994011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-79940112021-03-29 Reduced S100 Protein Expression in Malignant Ossifying Fibromyxoid Tumors: A Case Report Foster-Davies, Harri Jessop, Zita M. Clancy, Rachel M. Vijayasurej, Kerrin Vass, Johanne Bragg, Thomas Brotto, Maurizio Plast Reconstr Surg Glob Open Experimental Ossifying fibromyxoid tumor of soft parts (OFMT) is a rare mesenchymal neoplasm of uncertain lineage. OMFT normally has a benign clinical course, and malignant variants are considered unusual. Criteria defining malignancy have not yet been clearly identified and universally accepted, and there is diagnostic uncertainty between pathologists as to how best to recognize a malignant variant. We present the case of a 68-year-old male patient who, following initial diagnosis of typical OFMT in the left scapular region, presented to the sarcoma service 9 years later with a short history of a solid lesion in the right calf. Biopsy confirmed metastatic OFMT and further imaging identified three other radiologically similar but distant lesions, which were later resected. The histology of the initial biopsy was reviewed, and the original observations were found to be accurate and due to current diagnostic criteria, the specimen was reported as typical. We propose that this case report contributes to a growing body of literature suggesting that negative S100 expression may be a useful feature in identifying and characterizing malignant OFMT. Lippincott Williams & Wilkins 2021-03-23 /pmc/articles/PMC7994011/ /pubmed/33786264 http://dx.doi.org/10.1097/GOX.0000000000003482 Text en Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Experimental Foster-Davies, Harri Jessop, Zita M. Clancy, Rachel M. Vijayasurej, Kerrin Vass, Johanne Bragg, Thomas Brotto, Maurizio Reduced S100 Protein Expression in Malignant Ossifying Fibromyxoid Tumors: A Case Report |
title | Reduced S100 Protein Expression in Malignant Ossifying Fibromyxoid Tumors: A Case Report |
title_full | Reduced S100 Protein Expression in Malignant Ossifying Fibromyxoid Tumors: A Case Report |
title_fullStr | Reduced S100 Protein Expression in Malignant Ossifying Fibromyxoid Tumors: A Case Report |
title_full_unstemmed | Reduced S100 Protein Expression in Malignant Ossifying Fibromyxoid Tumors: A Case Report |
title_short | Reduced S100 Protein Expression in Malignant Ossifying Fibromyxoid Tumors: A Case Report |
title_sort | reduced s100 protein expression in malignant ossifying fibromyxoid tumors: a case report |
topic | Experimental |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994011/ https://www.ncbi.nlm.nih.gov/pubmed/33786264 http://dx.doi.org/10.1097/GOX.0000000000003482 |
work_keys_str_mv | AT fosterdaviesharri reduceds100proteinexpressioninmalignantossifyingfibromyxoidtumorsacasereport AT jessopzitam reduceds100proteinexpressioninmalignantossifyingfibromyxoidtumorsacasereport AT clancyrachelm reduceds100proteinexpressioninmalignantossifyingfibromyxoidtumorsacasereport AT vijayasurejkerrin reduceds100proteinexpressioninmalignantossifyingfibromyxoidtumorsacasereport AT vassjohanne reduceds100proteinexpressioninmalignantossifyingfibromyxoidtumorsacasereport AT braggthomas reduceds100proteinexpressioninmalignantossifyingfibromyxoidtumorsacasereport AT brottomaurizio reduceds100proteinexpressioninmalignantossifyingfibromyxoidtumorsacasereport |